02/06/2016
This article was written by Doris Burtscher on behalf of the MSF Vienna Evaluation Unit.

Since Kyrgyzstan is one of the 27 high multidrug-resistant tuberculosis (MDR-TB) burden countries listed by the WHO, MSF started a drug-resistant tuberculosis project in Kara Suu District in 2012. A qualitative study was undertaken to understand the perception of TB and DR-TB in order to improve the effectiveness and acceptance of the MSF intervention and to support advocacy strategies for an ambulatory model of care.

Access the article via PLOS One